Home Blog of Signal Transduction DNA Damage/DNA Repair CRISPR/Cas9 Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7

This study aimed to enhance homology-directed repair (HDR) efficiency in CRISPR/Cas-mediated genome editing by targeting three key factors regulating the balance between HDR and non-homologous end joining (NHEJ): MAD2L2, SCAI, and Ligase IV. In order to achieve this, a cellular model using mutated eGFP was designed to monitor HDR events. Results showed that MAD2L2 knockdown and SCR7 treatment significantly improved HDR efficiency during Cas9-mediated HDR repair of the mutated eGFP gene in the HEK293T cell line. Fusion protein Cas9-SCAI did not improve HDR. This study is the first to demonstrate that MAD2L2 knockdown during CRISPR-mediated gene editing in HEK293T cells can increase precise correction by up to 10.2 times. The study also confirmed a moderate but consistent effect of SCR7, an inhibitor of Ligase IV, which increased HDR by 1.7 times. These findings provide valuable insights into improving HDR-based genome editing efficiency.

 

Comments:

The study you described aimed to enhance the efficiency of homology-directed repair (HDR) in CRISPR/Cas-mediated genome editing. HDR is a mechanism that repairs DNA breaks using a homologous DNA template, resulting in precise modifications. However, another repair mechanism called non-homologous end joining (NHEJ) can also occur, which often leads to random insertions or deletions.

The researchers targeted three key factors involved in regulating the balance between HDR and NHEJ: MAD2L2, SCAI, and Ligase IV. MAD2L2 is a protein involved in cell division, SCAI is a suppressor of cellular senescence, and Ligase IV is an enzyme involved in the final step of NHEJ repair.

To monitor HDR events, the researchers designed a cellular model using a mutated version of the eGFP gene. They used the CRISPR/Cas9 system to introduce targeted DNA breaks and evaluate the efficiency of HDR repair.

The results of the study showed that knockdown of MAD2L2 and treatment with SCR7, an inhibitor of Ligase IV, significantly improved HDR efficiency during Cas9-mediated repair of the mutated eGFP gene in HEK293T cells. Specifically, MAD2L2 knockdown increased precise correction by up to 10.2 times compared to the control group. SCR7 treatment had a moderate but consistent effect, increasing HDR by 1.7 times.

However, the fusion protein Cas9-SCAI did not improve HDR efficiency in this study. Further investigation is needed to understand the reasons behind this result.

Overall, this study provides valuable insights into enhancing HDR-based genome editing efficiency by targeting MAD2L2 and inhibiting Ligase IV. These findings have implications for improving the precision of CRISPR/Cas-mediated genome editing techniques.